- Home
- RENE vs FENC Comparison
RENE vs FENC Comparison
Compare RENE & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RENE
- FENC
- Stock Information
- Founded
- RENE 2021
- FENC 1996
- Country
- RENE United States
- FENC United States
- Employees
- RENE N/A
- FENC N/A
- Industry
- RENE Blank Checks
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RENE Finance
- FENC Health Care
- Exchange
- RENE Nasdaq
- FENC Nasdaq
- Market Cap
- RENE 151.4M
- FENC 172.8M
- IPO Year
- RENE 2022
- FENC 2001
- Fundamental
- Price
- RENE $11.66
- FENC $5.92
- Analyst Decision
- RENE
- FENC Strong Buy
- Analyst Count
- RENE 0
- FENC 2
- Target Price
- RENE N/A
- FENC $14.00
- AVG Volume (30 Days)
- RENE 3.4K
- FENC 165.5K
- Earning Date
- RENE 01-01-0001
- FENC 11-07-2024
- Dividend Yield
- RENE N/A
- FENC N/A
- EPS Growth
- RENE 42.92
- FENC N/A
- EPS
- RENE 0.43
- FENC N/A
- Revenue
- RENE N/A
- FENC $49,348,000.00
- Revenue This Year
- RENE N/A
- FENC $97.94
- Revenue Next Year
- RENE N/A
- FENC $11.50
- P/E Ratio
- RENE $26.90
- FENC N/A
- Revenue Growth
- RENE N/A
- FENC 278.09
- 52 Week Low
- RENE $10.93
- FENC $3.96
- 52 Week High
- RENE $11.67
- FENC $11.92
- Technical
- Relative Strength Index (RSI)
- RENE 63.75
- FENC 54.12
- Support Level
- RENE $11.64
- FENC $5.51
- Resistance Level
- RENE $11.65
- FENC $6.17
- Average True Range (ATR)
- RENE 0.00
- FENC 0.37
- MACD
- RENE -0.00
- FENC -0.08
- Stochastic Oscillator
- RENE 87.50
- FENC 32.61
About RENE Cartesian Growth Corporation II
Cartesian Growth Corp II is a blank check company.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.